NC
GSK icon

Napatree Capital’s GSK GSK Stock Holding History

Napatree Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$398K Sell
10,276
-1,243
-11% -$45.5K 0.22% 124
2024
Q4 		$390K Buy
11,519
+108
+0.9% +$3.89K 0.23% 117
2024
Q3 		$466K Sell
11,411
-846
-7% -$34.6K 0.33% 89
2024
Q2 		$472K Sell
12,257
-5,064
-29% -$213K 0.38% 82
2024
Q1 		$718K Sell
17,321
-2,368
-12% -$97.7K 0.69% 49
2023
Q4 		$730K Buy
+19,689
New +$707K 0.73% 49

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Napatree Capital's GSK Position: Q1 2025 in Review

Napatree Capital reduced its GSK (GSK) stake by 11% in Q1 2025, selling an estimated $45.5K and leaving 10,276 shares worth $398K. The position accounts for 0.22% of the portfolio, ranked #124.

Napatree Capital first reported a position in GSK in Q4 2023 and has held it in 6 quarters since. The position peaked at $730K in Q4 2023. 858 funds tracked by Wall St. Rank hold GSK as of Q1 2025.

  • Napatree Capital held 10,276 shares of GSK worth $398K as of Q1 2025.
  • Napatree Capital sold 1,243 GSK shares in Q1 2025, an estimated $45.5K.
  • GSK made up 0.22% of Napatree Capital's portfolio in Q1 2025, its #124 holding.
  • Napatree Capital first reported a position in GSK in Q4 2023 and has held it in 6 quarters since.
  • Napatree Capital's GSK position peaked at $730K in Q4 2023.
  • 858 funds tracked by Wall St. Rank held GSK as of Q1 2025.

Based on Napatree Capital's 13F filing for Q1 2025, filed 2 May 2025.